Identification of at-risk populations for cardiac amyloidosis: a multimodal machine learning development and validation study

31 August 2025 (09:27 - 09:45)

Organised by:

Video

Abstract

Slides

Sign in for access options

About the speaker

Doctor Clemens Spielvogel

Medical University of Vienna, Vienna (Austria)

4 More presentations in this session

Presentation thumbnail

State-of-the-art lecture on digital innovations in clinical practice

Professor P. Vardas (Heraklion, GR)

Presentation thumbnail

A health economic evaluation of the TriageHF Plus clinical care pathway for device-based remote monitoring of heart failure

Doctor J. Taylor (Manchester, GB)

Abstract Slides Video

Presentation thumbnail

Insight into pill-in-pocket oral anticoagulation therapy with continuous monitoring of atrial fibrillation using a patient-level computational model

Mr M. Cai (Maastricht, NL)

Abstract Slides Video

Presentation thumbnail

Cardiovascular synchronisation to music : blood pressure entrainment to expressive musical structures

Miss N. Cotic (London, GB)

Abstract Slides Video

Access the full session

Session thumbnail

Digital innovations in clinical practice

The Event

Event poster

ESC Congress 2025

31 August 2025 09:27 CET

You may be interested in

Congress Presentation

Detection and risk stratification of cardiac amyloidosis patients by integration of imaging and non-imaging data using a machine learning approach

Congress Presentation

Targeted deployment of AI-ECG for efficient screening of transthyretin amyloid cardiomyopathy using deep learning representations of longitudinal electronic health records

Congress Presentation

Echocardiographic screening for cardiac amyloidosis using artificial intelligence: A multi-site study for algorithm training and external validation.

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources